Supplementation with vitamin C and/or vitamin B6 in the prevention of Depo-Provera side effects in adolescents

Journal of Pediatric and Adolescent Gynecology

Volumn 15, Issue 3, 2002, Pages 153-158

  Harel, Zeev ^a,d   Biro, Frank ^b,c   Kollar, Linda ^b   Riggs, Suzanne ^a   Flanagan, Patricia ^a   Vaz, Rosalind ^a  

^a BROWN UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

Adolescence, weight gain; Adolescents; Depo Provera; Medroxyprogesterone acetate; Menstrual irregularity; Vitamin B6; Vitamin C

Indexed keywords

ASCORBIC ACID; GLUCOCORTICOID ANTAGONIST; MEDROXYPROGESTERONE ACETATE; PLACEBO; PYRIDOXINE; TRYPTOPHAN;

ADOLESCENT; APPETITE; ARTICLE; AWARENESS; BODY MASS; BODY WEIGHT DISORDER; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN BINDING; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TAMPON; TRYPTOPHAN METABOLISM; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ADOLESCENT; ASCORBIC ACID; BODY MASS INDEX; CONTRACEPTIVE AGENTS, FEMALE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUATION DISTURBANCES; PATIENT SATISFACTION; TREATMENT OUTCOME; VITAMIN B 6; WEIGHT GAIN;

EID: 0036324802     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-3188(02)00148-1     Document Type: Article

References (25)

1. Depo-Provera in adolescents: Effects of early second injection or prior oral contraception
2. Risk of contraceptive discontinuation among adolescents
3. Adolescents' reasons for, and experience after, discontinuation of the long-acting contraceptives Depo-Provera and Norplant
4. Effects of eostrone and progesterone on collagen and ascorbic acid content in the endometrium and myometrium of the rat
5. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women
6. Tyrosinase-like activity and estradiol binding in rat uterine nuclear extract
7. Adolescents' compliance with the use of oral contraceptive
8. The in vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate
9. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile
10. Influence of progesterone on serotonin metabolism: A possible causal factor for mood changes
11. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins
12. Treatment of anorexia and weight loss with megestrol acetate in patients with cancer or acquired immunodeficiency syndrome
13. Mifpristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity
14. 6 and glucocorticoid action
15. 6 reduces cortisone-induced cleft palate in the mouse
16. Disturbance of tryptophan metabolism and its correction during hormonal contraception
17. The role of tryptophan metabolites in regulating gluconeogenesis
18. A possible diabetogenic role for tryptophan metabolites and effects of xanthurenic acid on insulin
19. 6
20. Clinical assessment of treatment for prolonged bleeding in users of Norplant implants
21. A review of "once a month" combined injectable contraceptives
22. Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives
23. 6 on the side effects of a low-dose combined oral contraceptive
24. Depot medroxyprogesterone acetate use in inner-city minority adolescents: Continuation rates and characteristics of long-term users
25. Comparison of continuation rates for hormonal contraception among adolescents